title: Early determination of hepatitis C virus RNA may help to decide the duration of therapy for chronic hepatitis C virus genotype 2/3 infection.
authors.forename: Martin
authors.initials: M
authors.lastname: Lagging
authors.forename: Asa
authors.initials: A
authors.lastname: Alsiö
authors.forename: Nina
authors.initials: N
authors.lastname: Langeland
authors.forename: Court
authors.initials: C
authors.lastname: Pedersen
authors.forename: Martti
authors.initials: M
authors.lastname: Färkkilä
authors.forename: Mads Rauning
authors.initials: MR
authors.lastname: Buhl
authors.forename: Kristine
authors.initials: K
authors.lastname: Mørch
authors.forename: Kristoffer
authors.initials: K
authors.lastname: Hellstrand
authors.forename: Gunnar
authors.initials: G
authors.lastname: Norkrans
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage*; D016174:Hepacivirus / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D011092:Polyethylene Glycols / Q000008:administration & dosage*; D012367:RNA, Viral / Q000032:analysis*; D011994:Recombinant Proteins; D013997:Time Factors; D019562:Viral Load
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D012367:RNA, Viral; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a